EndoBarrier was highly effective in this setting in patients with advanced diabetes and obesity. Given the high cardiovascular and microvascular risk of these patients, benefits might outweigh risks. As an endoscopic procedure it is relatively simple and non-invasive. Early removal rates require monitoring and there needs to be increased focus on preventing complications but, on balance, EndoBarrier deserves further investigation as a potential treatment for wider use.
The United Kingdom’s first NHS Endobarrier service for advanced diabesity: 1-year outcomes for all 62 treated patients
Jan 7, 2020 | Publications & Abstracts